Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Properties of Myocardial Fibrosis Biomarkers on the Outcome of Atrial Fibrillation Ablation

NCT05179902 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT05179902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05179902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Properties of Myocardial Fibrosis Biomarkers on the Outcome of Atrial Fibrillation Ablation
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Observational
Overall status
Unknown status
Start date
January 20, 2022
Completion date
January 31, 2025
Enrollment
190 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

able to give his non opposition to participate to the study, af ablation (ecs recommendation2020&acs2014) either for paroxysmal af unresponsive to anti-arrhythmic treatment either for persisting symptomatic af, women and men over 18 years old